Achim Schlapbach

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 2

Top Topics

Peripheral Blood

Protein Protein

Top Venues

Nature chemical biology

Journal of medicinal chemistry

Novartis Institutes for BioMedical Research Basel

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novartis Institutes for BioMedical Research Basel Mar 01 1995

Switzerland

Sr. Investigator :: Global Discovery Chemistry

Publications

Juraj Velcicky, Matthias R Bauer, Achim Schlapbach, Guillaume Lapointe, Arndt Meyer, Markus Vögtle, Ernst Blum, Estelle Ngo, Catherine Rolando, Pierre Nimsgern, Sylvie Teixeira-Fouchard, Hansjoerg Lehmann, Pascal Furet, Frédéric Berst, Jens Schümann, Rowan Stringer, Patrice Larger, Cindy Schmid, Catriona T Prendergast, Simone Riek, Patrick Schmutz, Sylvie Lehmann, Jörg Berghausen, Clemens Scheufler, Jean-Michel Rondeau, Christoph Burkhart, Thomas Knoepfel, Nina Gommermann
Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors. Journal of medicinal chemistry (2024)
Jean Quancard, Theo Klein, Shan-Yu Fung, Martin Renatus, Nicola Hughes, Laura Israël, John J Priatel, Sohyeong Kang, Michael A Blank, Rosa I Viner, Jutta Blank, Achim Schlapbach, Paul Erbel, Jayachandran N Kizhakkedathu, Frédéric Villard, René Hersperger, Suzanne C Tough, Joerg Eder, Frédéric Bornancin, Christopher M Overall
An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient. Nature chemical biology 15 (3) (2019)